The main finding of the present study was that patients with CKD stages 3 and 4, without a diagnosis of cerebrovascular disease or dementia, had elevated plasma concentrations of NfL, p-Tau231 and GFAP compared with controls with normal mGFR. The gene discussed is GFAP; the disease is chronic kidney disease.